GovChime
Notice ID: fc27ae714d344a4097301224ecc8c67ePresolicitation

Notice of Intent to Sole Source : Acquisition of Services for the Manufacture of Clinical Grade Lentiviral Vector Encoding GPC2-CAR

Archived on May 15, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−04:00
Posted
May 7, 2024
Notice type
Presolicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
325414: Biological Product (except Diagnostic) Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH NCI
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75N91024Q00089
Notice ID
fc27ae714d344a4097301224ecc8c67e

Description

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Pediatric Oncology Branch (POB) plans to procure 250 ml of concentrated lentiviral vectors, on a sole source basis from: Expression Therapeutics, LLC 1860 Montreal RD Tucker, Georgia 30084 The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501(a) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 325414 (Biological Product (except Diagnostic) Manufacturing) and the business size standard is 1,250 Employees. This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Governments needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to Contracting Officer identified below by no later than 10:00 A.M. EST on Wednesday, May 15, 2024 (05/15/24). A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number 75N91024Q00089 on all correspondence.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N91024Q00089
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Pre-SolicitationCurrentMay 7, 2024

    Notice of Intent to Sole Source : Acquisition of Services for the Manufacture of Clinical Grade Lentiviral Vector Encoding GPC2-CAR

    Notice fc27ae714d344a4097301224ecc8c67e on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N91024Q00089

Archive Date

May 15, 2024

Office Address

Bethesda, MD, 20892